Charles Schwab Investment Management »

Fibrobiologics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $216k 70k 3.09
2024-06-30 $331k 66k 4.99

More positions owned by Charles Schwab Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Broadcom (AVGO)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Fundamental Intl (FNDF)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Charles Schwab Investment Management

Top funds holding Fibrobiologics

BlackRock
BlackRock
Geode Capital Management
State Street Corporation
Cascade Financial Partners
Vanguard Group
Northern Trust
Optivise Advisory Services
Requisite Capital Management
Bank of America Corporation
American Institute for Advanced Investment Management
Charles Schwab Investment Management
Advisor Group Holdings
HPM Partners
Bank of New York Mellon

View all funds holding Fibrobiologics